Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
3(30%)
Results Posted
40%(2 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_1
1
10%
Ph phase_4
2
20%
Ph not_applicable
1
10%
Ph phase_3
1
10%

Phase Distribution

1

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(4)
Completed(5)
Terminated(1)

Detailed Status

Completed5
Recruiting3
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (20.0%)
Phase 31 (20.0%)
Phase 42 (40.0%)
N/A1 (20.0%)

Trials by Status

completed550%
recruiting330%
not_yet_recruiting110%
terminated110%

Recent Activity

3 active trials
Showing 5 of 10
recruiting

REGistry of Long-term AnTithrombotic TherApy-2

NCT04347187
recruiting

Ongoing Registry of Treatment of Venous Thromboembolism

NCT03881345
completednot_applicable

Coronary Artery Ectasia in Elective Coronary Angiography : Predictors, Outcomes and Management

NCT03896321
completedphase_4

Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing

NCT03126214
recruiting

START-Register: Survey on Anticoagulated Patients Register

NCT02219984
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT04347187

REGistry of Long-term AnTithrombotic TherApy-2

Recruiting
NCT03881345

Ongoing Registry of Treatment of Venous Thromboembolism

Recruiting
NCT03896321Not Applicable

Coronary Artery Ectasia in Elective Coronary Angiography : Predictors, Outcomes and Management

Completed
NCT03126214Phase 4

Improving Stroke Prevention in Atrial Fibrillation Through Pharmacist Prescribing

Completed
NCT02219984

START-Register: Survey on Anticoagulated Patients Register

Recruiting
NCT04229758Phase 3

Restarting Anticoagulation After Traumatic Intracranial Hemorrhage

Not Yet Recruiting
NCT02984982Phase 4

Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia

Completed
NCT03292575

Study of the Follow-up of Stroke Treated With Anticoagulants

Completed
NCT03828162

Atrial Fibrillation: Risk and Benefits of Anti-coagulation in the Elderly

Completed
NCT00790842Phase 1

Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction

Terminated

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10